ロード中...

Metformin attenuates gefitinib-induced exacerbation of pulmonary fibrosis by inhibition of TGF-β signaling pathway

Interstitial lung disease (ILD) is a serious side-effect of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) treatment. Therefore, it is necessary to study underlying mechanisms for the development of pulmonary fibrosis induced by EGFR-TKI and potential approaches to attenuate...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Li, Li, Huang, Wenting, Li, Kunlin, Zhang, Kejun, Lin, Caiyu, Han, Rui, Lu, Conghua, Wang, Yubo, Chen, Hengyi, Sun, Fenfen, He, Yong
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4791254/
https://ncbi.nlm.nih.gov/pubmed/26497205
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!